Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hATG + CsA With or Without Eltrombopag in Severe Aplastic Anemia
NCT02099747Phase 3Completed
- Start
- Jul 2015
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of eltrombopag in aplastic anemia. Started Jul 2015; status: completed.
02
Drugs
eltrombopag
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on NCT02099747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02099747.